Kansas Governor issues proclamation to honor The University of Kansas Cancer Center’s earning highest designation from the National Cancer Institute
Kansas Governor Laura Kelly has proclaimed September “Comprehensive Cancer Centers Awareness Month” in recognition of The University of Kansas Cancer Center becoming designated as a “Comprehensive” cancer center by the National Cancer...
1-Sep-2022 9:05 PM EDT Add to Favorites
KU Cancer Center researchers discover that people with blood-related cancers have a higher chance of COVID breakthrough infections
Individuals with blood-related cancers are more likely to experience a COVID-19 infection even after being vaccinated, a University of Kansas Cancer Center study has found.
12-Aug-2022 9:30 AM EDT Add to Favorites
The University of Kansas Cancer Center earns National Cancer Institute’s most prestigious status —Comprehensive
The University of Kansas Cancer Center has been designated as a “Comprehensive” cancer center by the National Cancer Institute (NCI). This is the highest level of recognition awarded by the NCI and is the gold standard for cancer centers.
7-Jul-2022 10:30 AM EDT Add to Favorites
Researchers at The University of Kansas Cancer Center have released the results of a clinical trial that examined the effectiveness of varenicline in African Americans. In their study published in JAMA, African American daily smokers who were given...
14-Jun-2022 1:05 PM EDT Add to Favorites
About 95% of participants achieved a measurable immune response after vaccination, according to study published in JAMA Oncology.
11-May-2022 12:15 PM EDT Add to Favorites
A three-year $1.2 million Breakthrough Award grant from the Department of Defense will help researchers identify tailored treatments for people with triple-negative breast cancer. Priyanka Sharma, MD, breast medical oncologist, and Shane Stecklein,...
28-Feb-2022 12:05 PM EST Add to Favorites
Ten years ago, on Jan. 23, 2012, the brand-new University of Kansas Clinical Research Center opened its doors.
26-Jan-2022 11:40 AM EST Add to Favorites
Receiving CAR-T therapy sooner improves lymphoma survival, according to study published in New England Journal of Medicine
Axicabtagene ciloleucel, known by the brand name Yescarta, is significantly more effective than the current standard of care in treating people with large B-cell lymphoma who relapse after the first line of treatment.
17-Dec-2021 4:15 PM EST Add to Favorites
See All News
Triple-negative breast cancer expert Dr. Priyanka Sharma discusses latest research and clinical trial efforts.
18-Jul-2018 1:35 PM EDT
Jennifer Klemp, PhD, MPH, director of cancer survivorship and an associate professor at The University of Kansas Cancer Center, is interviewed by Oncology Nursing News. In this interview, Klemp offers insights on some of the critical issues that...
31-Oct-2016 9:30 AM EDT
KU Cancer Center researcher is finding out why ovarian cancer is resistant to certain types of chemo to eventually identify a different drug target.
30-Jun-2015 5:05 PM EDT